Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Gemcitabine, Cisplatin, and Abraxane in Advanced Biliary Cancers

NCT02392637 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.

NCT NCT02392637
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02392637 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Gemcitabine, Cisplatin, and Abraxane in Advanced Biliary Cancers
Lead sponsor
M.D. Anderson Cancer Center
Phase
Phase 2
Overall status
Completed
Start date
April 2, 2015
Completion date
August 13, 2020
Enrollment
62 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

stage iii intrahepatic cholangiocarcinoma ajcc v7, stage iiia gallbladder cancer ajcc v7, stage iiib gallbladder cancer ajcc v7, stage iva gallbladder cancer ajcc v7, stage iva intrahepatic cholangiocarcinoma ajcc v7, stage ivb gallbladder cancer ajcc v7, stage ivb intrahepatic cholangiocarcinoma ajcc v7, unresectable extrahepatic bile duct carcinoma, unresectable gallbladder carcinoma